IRIS
CALZETTA, Luigino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.802
NA - Nord America 8.116
EU - Europa 3.921
SA - Sud America 2.279
AF - Africa 636
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 6
Totale 24.780
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.887
SG - Singapore 4.540
VN - Vietnam 1.941
BR - Brasile 1.722
CN - Cina 1.233
IE - Irlanda 1.094
HK - Hong Kong 973
IT - Italia 494
SE - Svezia 486
ZA - Sudafrica 448
NL - Olanda 370
FR - Francia 366
DE - Germania 276
AR - Argentina 209
IN - India 202
RU - Federazione Russa 171
BD - Bangladesh 169
FI - Finlandia 169
GB - Regno Unito 124
AT - Austria 98
ID - Indonesia 97
MX - Messico 91
IQ - Iraq 88
CO - Colombia 84
EC - Ecuador 73
CA - Canada 68
PK - Pakistan 62
TR - Turchia 62
VE - Venezuela 58
JP - Giappone 48
CL - Cile 46
UA - Ucraina 42
EE - Estonia 38
MA - Marocco 38
PH - Filippine 38
PY - Paraguay 38
UZ - Uzbekistan 37
KR - Corea 36
TW - Taiwan 33
SA - Arabia Saudita 31
ES - Italia 29
CI - Costa d'Avorio 27
PL - Polonia 27
TH - Thailandia 27
MY - Malesia 26
BE - Belgio 25
PE - Perù 23
TN - Tunisia 22
KE - Kenya 21
AE - Emirati Arabi Uniti 20
EG - Egitto 19
AZ - Azerbaigian 18
IL - Israele 17
ET - Etiopia 15
JO - Giordania 15
LT - Lituania 15
AU - Australia 13
DZ - Algeria 13
JM - Giamaica 13
UY - Uruguay 13
BO - Bolivia 12
PT - Portogallo 12
DO - Repubblica Dominicana 11
KG - Kirghizistan 11
AL - Albania 10
OM - Oman 10
NI - Nicaragua 9
NP - Nepal 9
PS - Palestinian Territory 9
RS - Serbia 9
CH - Svizzera 8
HU - Ungheria 8
IR - Iran 8
AM - Armenia 7
HN - Honduras 7
KZ - Kazakistan 7
LB - Libano 7
RO - Romania 7
BG - Bulgaria 6
HR - Croazia 6
NZ - Nuova Zelanda 6
PA - Panama 6
BY - Bielorussia 5
PR - Porto Rico 5
SY - Repubblica araba siriana 5
XK - ???statistics.table.value.countryCode.XK??? 5
BH - Bahrain 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
GT - Guatemala 4
KW - Kuwait 4
LU - Lussemburgo 4
LY - Libia 4
NG - Nigeria 4
SN - Senegal 4
AO - Angola 3
BB - Barbados 3
BW - Botswana 3
MK - Macedonia 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 24.734
Salva come PNG Salva come JPEG
Città #
Singapore 2.118
Chandler 1.266
San Jose 1.261
Dublin 1.084
Hong Kong 935
Ashburn 921
Ho Chi Minh City 606
Santa Clara 452
Hanoi 438
Johannesburg 416
Dallas 401
Boardman 324
Lauterbourg 303
Beijing 278
Princeton 256
Helsinki 151
Des Moines 145
Munich 136
São Paulo 134
New York 131
Los Angeles 116
Haiphong 91
Wilmington 90
Moscow 84
Vienna 81
Shanghai 80
Rome 74
Da Nang 73
Council Bluffs 72
Columbus 65
Rio de Janeiro 60
Ann Arbor 59
Milan 53
Parma 50
Chicago 44
Buffalo 43
Tallinn 38
Hải Dương 37
Tashkent 34
Belo Horizonte 33
Marseille 33
Biên Hòa 32
Frankfurt am Main 32
The Dalles 32
Guangzhou 30
Tianjin 29
Baghdad 28
Dhaka 28
Tokyo 28
Abidjan 27
Curitiba 27
Brasília 26
Nuremberg 26
Hefei 25
Mexico City 25
Brooklyn 24
Brussels 24
Jakarta 24
Ninh Bình 24
Bologna 23
Guayaquil 23
London 23
Medellín 23
Naples 23
Phoenix 23
Porto Alegre 23
Warsaw 23
Salvador 22
Seattle 22
Quito 21
Buenos Aires 20
Fortaleza 20
Bremen 19
Campinas 19
Chennai 19
Denver 19
Fremont 19
Seoul 19
Toronto 19
Can Tho 18
Goiânia 18
Houston 18
Nairobi 18
Orem 18
Pune 18
Redmond 18
Atlanta 17
Baku 17
Montreal 17
Phủ Lý 17
Asunción 16
Bogotá 16
Caracas 16
Shenzhen 16
Amman 15
Bắc Ninh 15
Manaus 15
Norwalk 15
Erbil 14
Lahore 14
Totale 14.325
Salva come PNG Salva come JPEG
Nome #
Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients 233
Distribution of the Clinical Manifestations of Alpha 1 Antitrypsin Deficiency in Respiratory Outpatients from an Area of Northern Italy 199
An Impairment in Resting and Exertional Breathing Pattern May Occur in Long-Covid Patients with Normal Spirometry and Unexplained Dyspnoea 190
The COPD assessment test and the modified Medical Research Council scale are not equivalent when related to the maximal exercise capacity in COPD patients 190
Small airways in asthma: from bench-to-bedside 188
Advances in understanding of mechanisms related to increased cardiovascular risk in COPD 176
Coronavirus Disease 2019: COSeSco - A Risk Assessment Score to Predict the Risk of Pulmonary Sequelae in COVID-19 Patients 154
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: An Italian Multicenter Study 153
Detection of Small Airway Dysfunction in Asthmatic Patients by Spirometry and Impulse Oscillometry System 151
Dexamethasone in patients hospitalized with COVID-19: Whether, when and to whom 151
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study 146
Ventilation Heterogeneity in Asthma and COPD: The Value of the Poorly Communicating Fraction as the Ratio of Total Lung Capacity to Alveolar Volume 138
Detection of small airway dysfunction in asymptomatic smokers with preserved spirometry: The value of the impulse oscillometry system 135
Oral corticosteroids dependence and biologic drugs in severe asthma: Myths or facts? a systematic review of real‐world evidence 132
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma 131
Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics 131
Clinical manifestations of a new alpha-1 antitrypsin genetic variant: Q0parma 128
A 6MWT index to predict O-2 flow correcting exercise induced SpO(2) desaturation in ILD 127
Advances with glucocorticoids in the treatment of asthma: state of the art 120
Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review 119
The impact of monoclonal antibodies on airway smooth muscle contractility in asthma: A systematic review 116
The Impact of Thermal Water in Asthma and COPD: A Systematic Review According to the PRISMA Statement 115
A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD 115
Breathing pattern and ventilatory response to exercise in patients with Chronic Obstructive Pulmonary Disease 114
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits 114
Sars-cov-2 neutralizing antibodies: A network meta-analysis across vaccines 114
Analysis of exhaled breath fingerprints and volatile organic compounds in COPD 112
Post-COVID-19 exaggerated exertional tachycardia: Relationship with pulmonary and cardiac sequelae 111
A safety comparison of LABA plus LAMA vs LABA plus ICS combination therapy for COPD 111
Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis 110
Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination 110
A pilot survey on the quality of life in respiratory rehabilitation carried out in COPD patients with severe respiratory failure: preliminary data of a novel Inpatient Respiratory Rehabilitation Questionnaire (IRRQ) 108
A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD 105
Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD 105
Cardiovascular disease in copd 105
Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review 104
Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis 103
Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis 103
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond 102
A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study 102
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score 100
Clinical efficacy of bronchodilators in equine asthma: Looking for minimal important difference 99
Corrigendum to “Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat” [Pulm. Pharmacol. Therapeut. (88), March 2025, 102342] (Pulmonary Pharmacology & Therapeutics (2025) 88, (S1094553924000580), (10.1016/j.pupt.2024.102342)) 98
Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat 96
A Novel and Effective Balanced Intravenous-Inhalant Anaesthetic Protocol in Swine by Using Unrestricted Drugs 95
Can placebo challenge test (Inducing a “nocebo effect”) be a suitable model to assess stress-induced bronchial obstruction? suggestions from the multidisciplinary working groups “stress-asthma” and “AAIITO regione campania” 95
Face masks during COVID-19 pandemic lockdown and self-reported seasonal allergic rhinitis symptoms 94
ACLIDINIUM/FORMOTEROL FIXED-DOSE COMBINATION FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 91
Factors influencing the efficacy of COVID-19 vaccines: A quantitative synthesis of phase III trials 91
Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs 90
An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma 89
A comprehensive overview of investigational elastase inhibitors for the treatment of acute respiratory distress syndrome 89
The interplay between diabetes mellitus and chronic obstructive pulmonary disease. An overview 88
Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma 88
Advances in adrenergic receptors for the treatment of chronic obstructive pulmonary disease: 2023 update 88
Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study 88
Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union 88
Animal models of chronic obstructive pulmonary disease and their role in drug discovery and development: a critical review 87
A narrative review on asthma and pest sensitization (cockroach, mouse and rat allergens): a social issue besides the medical problem 87
Targeting IL-5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab 87
Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today? 86
Medium-dose ICS-containing FDCs reduce all-cause mortality in COPD patients: an in-depth analysis of dual and triple therapies 85
Assessment of pet exposure by questionnaires in epidemiological studies (but also in clinical practice!): Why the questions should be simplified? 84
Onset of action of budesonide/formoterol Spiromax (R) compared with budesonide/formoterol Turbuhaler (R) in patients with COPD 84
Dog allergy: can a prevalent or exclusive sensitization to Can f 5 be considered a lucky or negative event in real life? 84
Asthma and comorbidities: recent advances 83
Preclinical Evaluation of an Inhibitor of Cytosolic Phospholipase A(2)alpha for the Treatment of Asthma 82
Multi-walled carbon nanotubes induce airway hyperresponsiveness in human bronchi by stimulating sensory C-fibers and increasing the release of neuronal acetylcholine 82
Long-acting muscarinic antagonists under investigational to treat chronic obstructive pulmonary disease 82
Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment 82
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids? 81
The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review 81
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement 80
Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses 80
Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review 80
Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients 80
Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol 80
Long-acting bronchodilators and synergistic interaction: a challenge across the currently available LABA/LAMA combinations 79
SMART for the treatment of asthma: A network meta-analysis of real-world evidence 79
Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways 79
Brensocatib: Dipeptidyl peptidase 1 (DPP1) inhibitor Treatment of non-cystic fibrosis bronchiectasis 79
Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease 78
Impact of Airway-Occluding Mucus Plugs on Mortality in Patients with COPD According to Disease Severity: A Subset Analysis of Data From COPDGene 78
Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD 78
Dysfunction of small airways and prevalence, airway responsiveness and inflammation in asthma: much more than small particle size of pet animal allergens 77
Synergistic interaction between beclomethasone diproprionate and formoterol fumarate in an ex vivo model of bronchial asthma 77
Unmet needs and relationship between general practitioners (GPS) and allergists living in Campania region (Southern Italy) 77
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review 76
Allergy in adolescent population (14-18 years) living in Campania region (southern Italy). A multicenter study 76
Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach? 76
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis 76
Reply to Han et al.: impact on mortality of triple ICS/LABA/LAMA therapy in a population of COPD patients including also subjects with asthma-like profile 76
Sex differences in COPD management 76
Beclomethasone dipropionate and sodium cromoglycate protect against airway hyperresponsiveness in a human ex vivo model of cow's milk aspiration 76
Optimizing drug delivery in COPD: The role of inhaler devices 75
Effect of lipopolysaccharide on the responsiveness of equine bronchial tissue 75
Emerging drugs for chronic obstructive pulmonary disease 75
Experimental glucocorticoid receptor agonists for the treatment of asthma: A systematic review 75
Asthma and COPD in an Italian adult population: Role of BMI considering the smoking habit 74
TSLP Inhibitors for Asthma: Current Status and Future Prospects 74
Totale 10.256
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.281
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.281
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 5 5
2021/20221.118 1 10 2 20 76 39 257 75 46 3 37 552
2022/20233.941 509 313 229 258 277 455 48 276 1.378 28 134 36
2023/20241.415 100 161 56 65 141 259 103 82 63 99 102 184
2024/20255.424 49 330 454 273 543 512 210 238 762 563 339 1.151
2025/202613.081 951 1.286 1.816 1.474 1.949 483 1.338 496 1.972 1.044 272 0
Totale 25.278